RELAPSED OSTEOSARCOMA
Clinical trials for RELAPSED OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for RELAPSED OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to tackle tough bone cancer
Disease control Recruiting nowThis early-stage trial tests a new drug called tegavivint combined with the chemotherapy gemcitabine in 24 people whose osteosarcoma (a type of bone cancer) has returned or not responded to prior treatment. The main goal is to find the safest dose of tegavivint when given with ge…
Matched conditions: RELAPSED OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immune cell combo shows promise for tough childhood cancers
Disease control Recruiting nowThis early-phase trial is testing whether giving children with advanced neuroblastoma or osteosarcoma a special type of immune cell (gamma delta T cells) from a healthy donor, along with several standard cancer drugs, is safe and tolerable. The study will enroll 24 children aged …
Matched conditions: RELAPSED OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC